Atypical antipsychotic efficacy and safety in managing delirium: A systematic review and critical analysis;Efficacité et innocuité des antipsychotiques atypiques dans le traitement du delirium: Revue systématique et synthè se critique

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 7, Issue 2, 2009, Pages 109-119

  Pelland, Camille ^a   Trudel, Jean François ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Antipsychotic agents; Delirium; Olanzapine; Quetiapine; Review; Risperidone

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGITATION; CLINICAL TRIAL; DELIRIUM; DRUG EFFICACY; DRUG SAFETY; EMBASE; EXTRAPYRAMIDAL SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; MEDLINE; PROSPECTIVE STUDY; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SYMPTOM; SYSTEMATIC REVIEW;

EID: 67249147227     PISSN: 17601703     EISSN: 19506988     Source Type: Journal    
DOI: 10.1684/pnv.2009.0165     Document Type: Review

References (44)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, Text Revision. Washington : American Psychiatric Association, 2000.
2. Stewart N, Fairweather S. Delirium : the physician's perspective. In : Jacoby R, Oppenheimer C, eds. Psychiatry in the elderly. Oxford : Oxford University Press, 2002 : 592-615.
3. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Delirium. Am J Psychiatry 1999 ; 156 (5 Suppl.) : 1-20. (Pubitemid 29220060)
4. George J, Bleasdale S, Singleton SJ. Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing 1997 ; 26 : 423-427 (Pubitemid 28014905)
5. Meagher DJ. Delirium : optimising management. BMJ 2001 ; 322 : 144-149
6. Ely EW, Stephens R, Jackson J, Thomason J, Truman B, Gordon S, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit : A survey of 912 healthcare professionals. Crit Care Med 2004 ; 32 : 106-112 (Pubitemid 38125570)
7. Michaud L, Büla C, Berney A, Camus V, Voellinger R, Stiefel F, et al. Delirium : guidelines for general hospitals. J Psychosom Res 2007 ; 62 : 371-383 (Pubitemid 46299081)
8. Potter J, George J. The prevention, diagnosis and management of delirium in older people : concise guidelines. Clin Med 2006 ; 6 : 303-308 (Pubitemid 43954031)
9. Overshott R, Karim S, Burns A. Cholinesterase inhibitors for delirium. Cochrane Database of Syst Rev 2008 ; 1 (CD005317). (Pubitemid 351807509)
10. Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R. Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 2005 ; 13 : 1100-1106 (Pubitemid 46638655)
11. Han CS, Kim YK. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004 ; 45 : 293-301.
12. Parellada E, Baeza I, de Pablo J, Martinez G. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004 ; 65 : 348-353
13. Sipahimalani A, Sime RM, Masand PS. Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1997 ; 1 : 24-26 (Pubitemid 28228506)
14. Horikawa N, Yamazaki T, Miyamoto K, Kurosawa A, Oiso H, Matsumoto F, et al. Treatment of delirium with risperidone : results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003 ; 25 : 289-292 (Pubitemid 36802275)
15. Mittal D, Jimerson NA, Neely EP, Johnson WD, Kennedy RE, Torres R, et al. Treatment of delirium with risperidone : results from a prospective open-label trial. J Clin Psychiatry 2004 ; 65 : 662-667
16. Miyaji S, Yamamoto K, Hoshino S, Yamamoto H, Sakai Y, Miyaoka H. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry Clin Neurosci 2007 ; 61 : 275-282 (Pubitemid 46683993)
17. Liu CY, Juang YY, Liang HY, Lin NC, Yeh EK. Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004 ; 19 : 165-168 (Pubitemid 38586489)
18. Lee KU, Won WY, Lee HK, Kweon YS, Lee CT, Pae CU, et al. Amisulpride versus quetiapine for the treatment of delirium : a randomized, open prospective study. Int Clin Psychopharmacol 2005 ; 20 : 311-314 (Pubitemid 41475320)
19. Omura K, Amano N. Clinical experience of quetiapine in 24 elderly patients with delirium. Psychogeriatrics 2003 ; 3 : 69-72.
20. Pae CU, Lee SJ, Lee CU, Lee C, Paik IH. A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol Clin Exp 2004 ; 19 : 125-127 (Pubitemid 38332060)
21. Maneeton B, Maneeton N, Srisurapanont M. An open-label study of quetiapine for delirium. J Med Assoc Thaï2007 ; 90 : 2158-2162 (Pubitemid 350063819)
22. Sasaki Y, Matsuyama T, Inoue S, Sunami T, Inoue T, Denda K, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003 ; 64 : 1316-1321 (Pubitemid 37490236)
23. Kim KY, Bader GM, Kotlyar V, Gropper D. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003 ; 16 : 29-31. (Pubitemid 37408287)
24. Schwartz TL, Masand PS. Treatment of delirium with quetiapine. Primary Care Companion J Clin Psychiatry 2000 ; 2 : 10-12
25. Hua H, Wei D, Hui Y, Yu L. Olanzapine and haloperidol for senile delirium: a randomized controlled observation. Chinese Journal of Clinical Rehabilitation 2006 ; 10 : 188-190 (Pubitemid 46055862)
26. Skrobik YK, Bergeron N, Dumont M, Gottfried S. Olanzapine vs haloperidol : treating delirium in a critical care setting. Intensive Care Med 2004 ; 30 : 444-449 (Pubitemid 38375619)
27. Kim KS, Pae CU, Chae JH, Bahk WM, Jun T. An open trial of olanzapine for delirium in the Korean population. Psychiatry Clinical Neurosci 2001 ; 55 : 515-519 (Pubitemid 32938807)
28. Breitbart W, Tremblay A, Gibson C. An Open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002 ; 43 : 175-182 (Pubitemid 34522527)
29. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics 1998 ; 39 : 422-430 (Pubitemid 28439942)
30. Straker DA, Shapiro PA, Muskin PR. Aripiprazole in the treatment of delirium. Psychosomatics 2006 ; 47 : 385-391
31. Alao AO, Moskowitz L. Aripiprazole and delirium. Ann Clin Psychiatry 2006 ; 18 : 267-269
32. Leso L, Schwartz T. Ziprasidone treatment of delirium. Psychosomatics 2002 ; 43 : 61-62 (Pubitemid 34214164)
33. Young CC, Lujan E. Intravenous ziprasidone for treatment of delirium in the intensive care unit. Anesthesiology 2004 ; 101 : 794-795 (Pubitemid 39121662)
34. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, et al. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002 ; 59 : 441-448 (Pubitemid 34477680)
35. Raveendran NS, Tharyan P, Alexander J, Adams CE. Rapid tranquilisation in psychiatric emergency settings in India : pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 2007 ; 335 : 865-873 (Pubitemid 350069461)
36. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005 ; 11 (Suppl. 1) : 5-108.
37. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 2004 ; 65 (Suppl. 2) : 5-99.
38. Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Mahmoud RA, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008 ; 56 : 1333-1341
39. Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, et al. ACNP white paper : update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008 ; 33 : 957-970
40. Pfizer Canada Inc, monographie du Zeldox (ziprasidone) décembre 2008 www.pfizer.ca/french/our%20products/prescription%20pharmaceuticals/default. asp?s=1&id=42&doc=frmonographconsulté janvier 2009.
41. Tesar GE, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985 ; 5 : 344-347 (Pubitemid 16213899)
42. Sanders KM, Cassem NH. Psychiatric complications in the critically ill cardiac patient. Tex Heart Inst J 1993 ; 20 : 180-187 (Pubitemid 23308044)
43. Wilt JL, Minnema AM, Johnson RF, Rosenblum AM, et al. Torsades de pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993 ; 119 : 391-394 (Pubitemid 23310089)
44. Seitz DP, Gill SS, vanZyl LT. Antipsychotics in the treatment of delirium : a systematic review. J Clin Psychiatry 2007 ; 68 : 11-21. (Pubitemid 46220119)